外科脓毒症后功能结局与长期死亡率的脂质及脂蛋白预测因子
该前瞻性队列研究纳入104例外科脓毒症患者,在脓毒症集束化治疗启动24小时内入外科ICU时采样检测脂质生物标志物,用多因素回归分析确定预测1年功能状态差(Zubrod评分3/4/5)或生存的独立危险因素。结果显示,1年功能状态差者入组时总胆固醇和高密度脂蛋白胆固醇(HDL-C)水平较低、髓过氧化物酶(MPO)水平较高;1年死亡者HDL-C和ApoA-I较低、MPO较高。但多因素logistic回归仅确定基线Zubrod评分和初始SOFA评分为1年功能状态差的显著独立预测因子;多因素Cox回归确定高Charlson共病评分、低ApoA-I水平和较长升压药使用时间预测脓毒症后1年死亡。作者认为脂蛋白未预测1年功能状态差,但ApoA-I、Charlson评分和升压药使用时间预测1年生存,提示胆固醇和脂蛋白可能参与脓毒症潜在病理生物学。
要点
- 104例外科脓毒症患者中,1年功能状态差者入组时总胆固醇和HDL-C较低、MPO较高,但多因素logistic回归仅基线Zubrod评分和初始SOFA评分为独立预测因子。
- 1年死亡者HDL-C和ApoA-I较低、MPO较高,多因素Cox回归确定高Charlson共病评分、低ApoA-I水平和较长升压药使用时间预测1年死亡。
- 脂蛋白(胆固醇、HDL-C)未能预测1年功能状态差,ApoA-I水平预测1年生存。
- 作者认为胆固醇和脂蛋白可能参与脓毒症潜在病理生物学。
适用人群与场景
- 脓毒症患者,入住外科ICU且在脓毒症集束化治疗启动24小时内入组。
诊断标准与关键阈值
- 功能状态差定义为Zubrod评分3/4/5。
研究设计与关键结果
- 前瞻性队列研究纳入104例外科脓毒症患者,入组时采样检测脂质生物标志物,多因素回归模型确定预测1年功能状态差(Zubrod评分3/4/5)或生存的独立危险因素。
- 1年功能状态差者入组时总胆固醇和HDL-C水平较低、MPO水平较高;1年死亡者HDL-C和ApoA-I较低、MPO较高。
- 多因素logistic回归仅确定基线Zubrod评分和初始SOFA评分为1年功能状态差的显著独立预测因子。
- 多因素Cox回归确定高Charlson共病评分、低ApoA-I水平和较长升压药使用时间预测脓毒症后1年死亡。
证据类型、等级与局限
- 证据类型:前瞻性队列研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为脂蛋白未预测1年功能状态差,ApoA-I水平、Charlson共病评分和升压药使用时间预测1年生存,这些数据提示胆固醇和脂蛋白可能参与脓毒症潜在病理生物学。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
RATIONALE: Sepsis is a life-threatening, dysregulated response to infection. Lipid biomarkers including cholesterol are dynamically regulated during sepsis and predict short-term outcomes. In this study, we investigated the predictive ability of lipid biomarkers for physical function and long-term mortality after sepsis.
METHODS: Prospective cohort study of sepsis patients admitted to a surgical intensive-care unit (ICU) within 24 h of sepsis bundle initiation. Samples were obtained at enrollment for lipid biomarkers. Multivariate regression models determined independent risk factors predictive of poor performance status (Zubrod score of 3/4/5) or survival at 1-year follow-up.
MEASUREMENTS AND MAIN RESULTS: The study included 104 patients with surgical sepsis. Enrollment total cholesterol and high-density lipoprotein (HDL-C) levels were lower, and myeloperoxidase (MPO) levels were higher for patients with poor performance status at 1 year. A similar trend was seen in comparisons based on 1-year mortality, with HDL-C and ApoA-I levels being lower and MPO levels being higher in non-survivors. However, multivariable logistic regression only identified baseline Zubrod and initial SOFA score as significant independent predictors of poor performance status at 1 year. Multivariable Cox regression modeling for 1-year survival identified high Charlson comorbidity score, low ApoA-I levels, and longer vasopressor duration as predictors of mortality over 1-year post-sepsis.
CONCLUSIONS: In this surgical sepsis study, lipoproteins were not found to predict poor performance status at 1 year. ApoA-I levels, Charlson comorbidity scores, and duration of vasopressor use predicted 1 year survival. These data implicate cholesterol and lipoproteins as contributors to the underlying pathobiology of sepsis.
参考来源
- Guirgis FW, Leeuwenburgh C, Moldawer L, et al. Lipid and lipoprotein predictors of functional outcomes and long-term mortality after surgical sepsis. Ann Intensive Care. 2021. PMID: 34018068. doi:10.1186/s13613-021-00865-x
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。